↓ Skip to main content

Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery.

Overview of attention for article published in Current Cancer Drug Targets, February 2008
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)

Mentioned by

patent
7 patents

Readers on

mendeley
35 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery.
Published in
Current Cancer Drug Targets, February 2008
DOI 10.2174/156800908783497159
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Japan 1 3%
United Kingdom 1 3%
Unknown 33 94%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Doctoral Student 4 11%
Student > Ph. D. Student 4 11%
Researcher 3 9%
Student > Postgraduate 3 9%
Other 2 6%
Other 8 23%
Unknown 11 31%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 6 17%
Medicine and Dentistry 6 17%
Biochemistry, Genetics and Molecular Biology 4 11%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Immunology and Microbiology 2 6%
Other 6 17%
Unknown 9 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2025.
All research outputs
#7,642,348
of 34,559,526 outputs
Outputs from Current Cancer Drug Targets
#135
of 740 outputs
Outputs of similar age
#39,936
of 234,193 outputs
Outputs of similar age from Current Cancer Drug Targets
#2
of 10 outputs
Altmetric has tracked 34,559,526 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 740 research outputs from this source. They receive a mean Attention Score of 4.8. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 234,193 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 8 of them.